학술논문
A randomized phase I/II study of everolimus, irinotecan, and cetuximab versus capecitabine and oxaliplatin in gemcitabine-resistant patients with pancreatic cancer.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755